Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Dohoney
K. Dohoney
Melanoma
Dosing
Pharmacology
Medicine
Dovitinib Lactate
2
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Results from the first-in-human (FIH) phase I study of the oral RAF inhibitor RAF265 administered daily to patients with advanced cutaneous melanoma.
2011
Journal of Clinical Oncology
William H. Sharfman
F.S. Hodi
D.P. Lawrence
Keith T. Flaherty
Ravi K. Amaravadi
K. B. Kim
Reinhard Dummer
S. Gobbi
I. Puzanov
J. A. Sosman
K. Dohoney
L. P. Lam
Shefali Kakar
Zhongwen Tang
O. Krieter
Michael B. Atkins
Show All
Source
Cite
Save
Citations (46)
The pharmacodynamic effect of TKI258 on plasma biomarkers of angiogenesis in patients with AML and advanced melanoma
2008
Journal of Clinical Oncology
M. M. Shi
M. Motwani
J. Wang
M. Steed
K. Dohoney
J.Saro
R Wasserman
J. C. Barrett
Show All
Source
Cite
Save
Citations (4)
1